Recently, GSH Bio-Tech application for a method of enzymatic preparation of glutathione has granted a patent certificate by the United States Patent and Trademark Office, with patent number US11788110B2.
![New patents New patents](https://gshbio.com/wp-content/uploads/2023/12/640-781x1024.png)
![New patents New patents](https://gshbio.com/wp-content/uploads/2023/12/640-1-781x1024.png)
Every year, only about half of all patent applications in the United States ultimately approved by the US Patent Office. After rigorous examination, ANHUI GSH BIO-TECHNOLOGY CO., LTD has awarded a US patent, proving the uniqueness and superiority of GSHWORLD production technology.
In recent years, the technology for enzymatic production of glutathione has gradually improved. ANHUI GSH BIO-TECHNOLOGY CO., LTD, as the pioneer of global enzymatic catalytic coupling ATP regeneration technology, has achieved ATP regeneration with its new enzymatic production technology, which is low-cost, less polluting, and has multiple independent intellectual property rights.
At present, GSH BIO-TECH has achieved commercial production of products such as glutathione, NMN,
and Citicoline Sodium, with an annual production capacity of up to 1000 tons of glutathione.
![Cytidine sodium has an annual production capacity of 200 tons Cytidine sodium has an annual production capacity of 200 tons](https://gshbio.com/wp-content/uploads/2023/11/High-Quality-Citicoline-CAS-No-987-78-0-Citicoline-Powder1-1024x1024.webp)
![NMN annual production capacity 400 tons NMN annual production capacity 400 tons](https://gshbio.com/wp-content/uploads/2023/11/Wholesale-Dietary-Supplements-Nicotinamide-Mononucleotide-CAS-1094-61-7-1-1024x1024.webp)
![Annual production capacity of glutathione is 1000 tons Annual production capacity of glutathione is 1000 tons](https://gshbio.com/wp-content/uploads/2023/11/Skin-Care-Skin-Whitening-L-Glutathione-Reduced-CAS-70-18-8-1-1024x1024.webp)
GSHWORLD has always adhered to green environmental protection, technological innovation, and global layout. The company equipped with advanced research equipment and an experienced research team, and has developed glutathione β- The production technology of nicotinamide mononucleotide and sodium cytidine is internationally leading.
![Multiple patents Multiple patents](https://gshbio.com/wp-content/uploads/2023/12/640-2-1024x576.png)
Over 13 years of research and development, a total of 22 Chinese invention patents,
1 utility model patent, and 2 international invention patents have applied for.
12 Chinese invention patents, 1 utility model patent, 1 international invention patent (authorized by the United States),
and 8 software copyrights have been granted.
In the future, ANHUI GSH BIO-TECH will pay more attention to innovative research and development of high value-added raw materials,
important pharmaceutical intermediates,
and cosmetic raw materials, and continue to optimize production technology to provide customers worldwide with higher quality and satisfactory products.